Global Blood Therapeutics (GBT) Tops Q1 EPS by 4c
Tweet
Share
E-mail
Get Alerts GBT Hot Sheet
Price: $68.49 --0%
Financial Fact:
Research and development expenses: 298.26K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Research and development expenses: 298.26K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Global Blood Therapeutics (NASDAQ: GBT) reported Q1 EPS of ($1.26), $0.04 better than the analyst estimate of ($1.30). Revenue for the quarter came in at $55.16 million versus the consensus estimate of $56.14 million.
For earnings history and earnings-related data on Global Blood Therapeutics (GBT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- UBS says bull market has further to run
- Bernstein remains bullish on SpaceX but sees challenges in telecom ambitions
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
